Published in J Clin Microbiol on August 01, 1998
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol (1999) 5.58
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol (2002) 3.30
Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol (2003) 3.08
Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol (2006) 3.05
Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol (2004) 2.82
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.50
tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol (2006) 2.49
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol (2010) 2.29
Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol (2003) 2.24
Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis (2009) 2.24
Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol (2004) 2.11
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol (2006) 1.87
Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard. J Clin Microbiol (2010) 1.85
Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol (2002) 1.83
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol (2004) 1.73
Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl Environ Microbiol (2007) 1.71
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol (2006) 1.71
New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol (2003) 1.61
Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol (2004) 1.60
Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun (2000) 1.60
Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis (2006) 1.52
Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol (2008) 1.47
Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence. Clin Infect Dis (2015) 1.45
Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol (2003) 1.43
Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One (2012) 1.40
The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes (2010) 1.37
Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl Environ Microbiol (2009) 1.32
Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile. PLoS One (2011) 1.29
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. J Clin Microbiol (2000) 1.28
Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol (2009) 1.24
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol (2003) 1.23
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol (2000) 1.18
Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol (2011) 1.16
Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC Microbiol (2012) 1.14
International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol (2014) 1.09
Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification. J Clin Microbiol (2005) 1.07
Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes (2011) 1.06
Epidemic Clostridium difficile strain in hospital visitation dog. Emerg Infect Dis (2006) 1.05
Clostridium difficile strains from community-associated infections. J Clin Microbiol (2009) 1.03
Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J Med Microbiol (2011) 1.02
Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis (2012) 1.01
The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci (2009) 1.00
Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect (2014) 1.00
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Prevalence and diversity of toxigenic Clostridium perfringens and Clostridium difficile among swine herds in the midwest. Appl Environ Microbiol (2010) 0.98
Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes. PLoS One (2013) 0.98
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth. PLoS One (2016) 0.96
Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev (2015) 0.94
Clostridium difficile infection in an Iranian hospital. BMC Res Notes (2012) 0.93
Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther (2014) 0.92
Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm. Appl Environ Microbiol (2012) 0.92
Carriage of Clostridium difficile by wild urban Norway rats (Rattus norvegicus) and black rats (Rattus rattus). Appl Environ Microbiol (2013) 0.90
Clostridium difficile and methicillin-resistant Staphylococcus aureus shedding by slaughter-age pigs. BMC Vet Res (2011) 0.90
Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection. Infect Immun (2011) 0.89
Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus. Sci Rep (2015) 0.88
Array comparative hybridisation reveals a high degree of similarity between UK and European clinical isolates of hypervirulent Clostridium difficile. BMC Genomics (2010) 0.88
Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains? J Clin Microbiol (2011) 0.88
An Update on Clostridium difficile Toxinotyping. J Clin Microbiol (2015) 0.87
Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea. J Clin Microbiol (2005) 0.87
The identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment. BMC Infect Dis (2013) 0.86
Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile. Antimicrob Agents Chemother (2008) 0.86
Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. PLoS One (2015) 0.85
Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007. Emerg Infect Dis (2011) 0.85
Clostridium difficile in ground meat, France. Emerg Infect Dis (2010) 0.84
Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis (2012) 0.84
Clostridium difficile in retail baskets, trolleys, conveyor belts, and plastic bags in Saudi Arabia. Saudi Med J (2014) 0.84
Genotypic investigation of Clostridium difficile in Prince Edward Island. Can J Infect Dis Med Microbiol (2008) 0.82
Prevalence of Clostridium difficile in retail pork. Can Vet J (2010) 0.82
Molecular epidemiology of Clostridium difficile at a medical center in Taiwan: persistence of genetically clustering of A⁻B⁺ isolates and increase of A⁺B⁺ isolates. PLoS One (2013) 0.82
Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region. J Biol Chem (2015) 0.81
Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. Eur J Clin Microbiol Infect Dis (2014) 0.81
The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5. Genome Biol Evol (2014) 0.81
Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin. J Clin Microbiol (2012) 0.81
A prospective study to examine the epidemiology of methicillin-resistant Staphylococcus aureus and Clostridium difficile contamination in the general environment of three community hospitals in southern Ontario, Canada. BMC Infect Dis (2012) 0.81
In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119. Anaerobe (2011) 0.81
Susceptibility of hamsters to Clostridium difficile isolates of differing toxinotype. PLoS One (2013) 0.80
Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection. Appl Environ Microbiol (2016) 0.80
Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms. PLoS One (2013) 0.79
Recombination drives evolution of the Clostridium difficile 16S-23S rRNA intergenic spacer region. PLoS One (2014) 0.78
Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences. PLoS One (2015) 0.77
Molecular characterization of Clostridium tetani strains by pulsed-field gel electrophoresis and colony PCR. Appl Environ Microbiol (2005) 0.76
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response. Vaccine (2013) 0.76
Longitudinal study of Clostridium difficile shedding in raccoons on swine farms and conservation areas in Ontario, Canada. BMC Vet Res (2015) 0.76
DNA microarray-based PCR ribotyping of Clostridium difficile. J Clin Microbiol (2014) 0.75
Bacterial probiotics as an aid in the control of Clostridium difficile disease in neonatal pigs. Can Vet J (2016) 0.75
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals. PLoS One (2017) 0.75
Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities. Infect Immun (2016) 0.75
Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile. Int J Nanomedicine (2016) 0.75
Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea. PLoS One (2016) 0.75
Identification of risk factors influencing Clostridium difficile prevalence in middle-size dairy farms. Vet Res (2016) 0.75
Genome Sequence of a Toxin-Positive Clostridium difficile Strain Isolated from Murine Feces. Genome Announc (2017) 0.75
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates. J Clin Microbiol (1992) 3.56
Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol (1993) 3.01
Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest (1995) 2.91
Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene (1996) 2.87
Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85
Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis (1994) 2.51
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49
Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1986) 2.43
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.07
Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00
Serotyping of Clostridium difficile. J Clin Microbiol (1988) 1.98
The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog (1995) 1.89
Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett (1997) 1.88
Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol Microbiol (1995) 1.81
Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol (1993) 1.78
Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol (1996) 1.48
Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reaction. J Med Microbiol (1993) 1.38
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism. J Clin Microbiol (1997) 1.37
Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C. J Clin Microbiol (1996) 1.31
Characterization of flagella of Clostridium difficile and their role in serogrouping reactions. J Clin Microbiol (1990) 1.26
Molecular screening of Clostridium difficile toxins A and B genetic determinants and identification of mutant strains. FEMS Microbiol Lett (1991) 1.06
Restriction fragment length polymorphism of flagellin genes of Campylobacter jejuni and/or C. coli isolates from Egypt. J Clin Microbiol (1996) 1.01
Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect (2007) 3.27
The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem (1995) 3.02
Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene (1996) 2.87
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1986) 2.43
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Omeprazole, campylobacter pylori, and duodenal ulcer. Lancet (1989) 2.24
Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09
Serotyping of Clostridium difficile. J Clin Microbiol (1988) 1.98
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94
Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett (1997) 1.88
Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun (2001) 1.85
Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol (1993) 1.78
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun (1994) 1.68
A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem (1999) 1.58
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
Nucleotide sequence of Clostridium difficile toxin A. Nucleic Acids Res (1990) 1.55
Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet (1987) 1.52
The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J Clin Invest (1995) 1.51
Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864--implications for transcription, expression and enzymatic activity of toxins A and B. Mol Gen Genet (1998) 1.49
Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J Biol Chem (1996) 1.39
Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C. J Clin Microbiol (1996) 1.31
The mode of spread of Campylobacter jejuni/coli to broiler flocks. Zentralbl Veterinarmed B (1988) 1.29
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
Characterization of flagella of Clostridium difficile and their role in serogrouping reactions. J Clin Microbiol (1990) 1.26
Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr (1988) 1.25
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol (2003) 1.23
Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother (1999) 1.23
Virulence of ten serogroups of Clostridium difficile in hamsters. J Med Microbiol (1990) 1.23
Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay. FEMS Microbiol Lett (1993) 1.23
First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill (2005) 1.22
Variant toxin B and a functional toxin A produced by Clostridium difficile C34. FEMS Microbiol Lett (2001) 1.22
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile. Antimicrob Agents Chemother (1986) 1.18
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol (2000) 1.18
Antibacterial activity of glass-ionomer cements, compomers and resin composites: relationship between acidity and material setting phase. J Oral Rehabil (2005) 1.18
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem (1997) 1.17
A chimeric ribozyme in clostridium difficile combines features of group I introns and insertion elements. Mol Microbiol (2000) 1.16
Brevibacterium paucivorans sp. nov., from human clinical specimens. Int J Syst Evol Microbiol (2001) 1.14
Inhibition of Fc epsilon-RI-mediated activation of rat basophilic leukemia cells by Clostridium difficile toxin B (monoglucosyltransferase) J Biol Chem (1996) 1.13
Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill (2008) 1.12
Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur J Epidemiol (1988) 1.12
Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping. J Clin Microbiol (1993) 1.12
Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin. Infect Immun (1995) 1.11
Epidemiology and prevention of Clostridium difficile infections in a leukemia unit. Eur J Clin Microbiol (1987) 1.11
Antimicrobial activity of bark extracts of Syzygium jambos (L.) alston (Myrtaceae). J Ethnopharmacol (2000) 1.11
A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10
Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile. J Antimicrob Chemother (1988) 1.07
Molecular characterization of fliD gene encoding flagellar cap and its expression among Clostridium difficile isolates from different serogroups. J Clin Microbiol (2001) 1.06
The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol Lett (1997) 1.05
Identification of Arthrobacter oxydans, Arthrobacter luteolus sp. nov., and Arthrobacter albus sp. nov., isolated from human clinical specimens. J Clin Microbiol (2000) 1.04
Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clin Belg (1995) 1.04
UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii. J Biol Chem (1996) 1.04
Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. Eur J Clin Microbiol Infect Dis (2014) 1.02
Surveillance of human Yersinia enterocolitica infections in Belgium: 1967-1996. Clin Infect Dis (1998) 1.00
Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. Eur J Clin Microbiol Infect Dis (1995) 0.99
Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol (1997) 0.99
Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg (2001) 0.98
Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins. J Biol Chem (1996) 0.98
Detection of specific antigens for ten serogroups of Clostridium difficile. Mol Cell Probes (1990) 0.97
Chronic osteomyelitis due to Actinomyces neuii subspecies neuii and Dermabacter hominis. Eur J Clin Microbiol Infect Dis (2002) 0.97
Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (2000) 0.97
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.96
Evaluation of the Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in human samples. J Clin Microbiol (1999) 0.96
Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe (2006) 0.95
Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. Eur J Clin Microbiol Infect Dis (2013) 0.94
Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol Gen Genet (1995) 0.93
Heterogeneity of Clostridium difficile isolates from infants. Eur J Pediatr (1993) 0.93
Legionella spp. in a hospital hot water system: effect of control measures. J Hosp Infect (1989) 0.93
Primary infection of ascitic fluid with Clostridium difficile. J Infect (1990) 0.91
A role for Rho in receptor- and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.91
Evaluation of pulsed-field gel electrophoresis and rep-PCR for the epidemiological analysis of Ochrobactrum anthropi strains. Eur J Clin Microbiol Infect Dis (1995) 0.91
Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. Br J Pharmacol (2000) 0.90
Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients. J Clin Microbiol (1993) 0.89
In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units. Eur J Clin Microbiol Infect Dis (2007) 0.89
Characterisation of cryptic plasmids in clinical isolates of Bacteroides fragilis. J Med Microbiol (1985) 0.89
Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases. J Biol Chem (1998) 0.89
Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton. Infect Immun (1992) 0.89
Demonstration that the group II intron from the Clostridial Conjugative transposon Tn5397 undergoes splicing In vivo. J Bacteriol (2001) 0.87
Clostridium difficile in young farm animals and slaughter animals in Belgium. Anaerobe (2012) 0.87
Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J Neurol Sci (1991) 0.86
UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J Biol Chem (1998) 0.85
Clostridium difficile toxins A and B inhibit human immune response in vitro. Infect Immun (1988) 0.85
Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. Biochim Biophys Acta (2000) 0.82
Prevalence and genetic heterogeneity of Borrelia burgdorferi sensu lato in Ixodes ticks in Belgium. Acta Clin Belg (2010) 0.82
Early identification of Mycobacterium tuberculosis and Mycobacterium avium using the polymerase chain reaction on samples positive by a rapid commercial culture system. Eur J Clin Microbiol Infect Dis (1999) 0.82
[The role of Clostridium difficile in diarrhea appearing after antibiotic treatment: a study of 87 cases]. Acta Clin Belg (1981) 0.81